Beijing Science Sun Pharmaceutical Co (SZSE:300485) Net Income (Continuing Operations) : ¥-199.1 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Beijing Science Sun Pharmaceutical Co's Net Income (Continuing Operations) for the three months ended in Sep. 2024 was ¥6.1 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-199.1 Mil.

Beijing Science Sun Pharmaceutical Co Net Income (Continuing Operations) Historical Data

The historical data trend for Beijing Science Sun Pharmaceutical Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Science Sun Pharmaceutical Co Net Income (Continuing Operations) Chart

Beijing Science Sun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

147.55

151.28

395.13

202.65

96.41

Beijing Science Sun Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-56.26	-96.88	-192.35	84.08	6.06

Beijing Science Sun Pharmaceutical Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-199.1 Mil.

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Beijing Science Sun Pharmaceutical Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Science Sun Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.ssyy.com.cn

Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.

Executives

Ma Li	Directors, executives
Kong Shuang Quan	Executives
Li Jian Hua	Director
Ma Biao	Directors, executives
Li Zhi Bing	Supervisors
Zhang Fan	Executives

Beijing Science Sun Pharmaceutical Co Headlines

No Headlines